Association of over-expressed TFDP1 with progression of hepatocellular carcinomas
- PMID: 14618416
- DOI: 10.1007/s10038-003-0086-3
Association of over-expressed TFDP1 with progression of hepatocellular carcinomas
Abstract
DP-1 is a heterodimerization partner for members of the E2F family of transcription factors; E2F/DP-1 regulates the expression of various cellular promoters, particularly gene products that are involved in the cell cycle. Our earlier studies identified the DP-1 gene ( TFDP1) as a probable target within a 13q34 amplicon that is frequently detected in hepatocellular carcinomas (HCC) and esophageal squamous-cell carcinomas. The aim of the present study was to investigate the clinicopathological significance of up-regulation of TFDP1 in HCC. We determined expression levels of TFDP1 and E2F1 in 41 primary HCCs by means of quantitative real-time reverse transcription-polymerase chain reactions, and looked for relationships between those data and various clinicopathological parameters. To assess transactivating activity of E2F1/DP-1, we also analyzed expression of ten putative transcriptional targets of this complex in HCCs. Using antisense oligonucleotides, we down-regulated TFDP1 in Hep3B, an HCC cell line that had shown overexpression of the gene, to examine the role of elevated TFDP1 expression in the growth of Hep3B cells. Elevated expression of TFDP1, but not E2F1, was associated significantly with large (> or =5 cm) tumor size (P=0.021). Expression levels of TFDP1 and E2F1 correlated with those of seven transcriptional targets ( TYMS, DHFR, PCNA, RRM1, CCNE1, CDC2, and MYBL2) that play important roles in the G1/S transition, and down-regulation of TFDP1 inhibited growth of Hep3B cells. In conclusion, overexpression of TFDP1 may contribute to progression of some HCCs by promoting growth of the tumor cells.
Similar articles
-
TFDP1, CUL4A, and CDC16 identified as targets for amplification at 13q34 in hepatocellular carcinomas.Hepatology. 2002 Jun;35(6):1476-84. doi: 10.1053/jhep.2002.33683. Hepatology. 2002. PMID: 12029633
-
The E2F transcription factor 1 transactives stathmin 1 in hepatocellular carcinoma.Ann Surg Oncol. 2013 Nov;20(12):4041-54. doi: 10.1245/s10434-012-2519-8. Epub 2012 Aug 22. Ann Surg Oncol. 2013. PMID: 22911364
-
The TFDP1 gene coding for DP1, the heterodimeric partner of the transcription factor E2F, is a target of deregulated E2F.Biochem Biophys Res Commun. 2023 Jun 30;663:154-162. doi: 10.1016/j.bbrc.2023.04.092. Epub 2023 Apr 25. Biochem Biophys Res Commun. 2023. PMID: 37141667
-
The role of the transcription factor DP in apoptosis.Apoptosis. 2003 Oct;8(5):461-8. doi: 10.1023/a:1025586207239. Apoptosis. 2003. PMID: 12975577 Review.
-
TFDP3 as E2F Unique Partner, Has Crucial Roles in Cancer Cells and Testis.Front Oncol. 2021 Oct 20;11:742462. doi: 10.3389/fonc.2021.742462. eCollection 2021. Front Oncol. 2021. PMID: 34745961 Free PMC article. Review.
Cited by
-
The synergistic interaction landscape of chromatin regulators reveals their epigenetic regulation mechanisms across five cancer cell lines.Comput Struct Biotechnol J. 2022 Sep 12;20:5028-5039. doi: 10.1016/j.csbj.2022.09.008. eCollection 2022. Comput Struct Biotechnol J. 2022. PMID: 36187922 Free PMC article.
-
Comprehensive characterization of the DNA amplification at 13q34 in human breast cancer reveals TFDP1 and CUL4A as likely candidate target genes.Breast Cancer Res. 2009;11(6):R86. doi: 10.1186/bcr2456. Epub 2009 Dec 8. Breast Cancer Res. 2009. PMID: 19995430 Free PMC article.
-
Identification and functional characterization of the transcription factor coding Dp1 gene in large yellow croaker Pseudosciaena crocea.Heliyon. 2021 Feb 26;7(2):e06299. doi: 10.1016/j.heliyon.2021.e06299. eCollection 2021 Feb. Heliyon. 2021. PMID: 33718639 Free PMC article.
-
Identification and validation of a five-gene prognostic signature for hepatocellular carcinoma.World J Surg Oncol. 2021 Mar 26;19(1):90. doi: 10.1186/s12957-021-02202-9. World J Surg Oncol. 2021. PMID: 33771191 Free PMC article.
-
Purification and identification of a transcription factor, USF-2, binding to E-box element in the promoter of human telomerase reverse transcriptase (hTERT).Proteomics. 2010 Jan;10(2):203-11. doi: 10.1002/pmic.200800693. Proteomics. 2010. PMID: 19899074 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Miscellaneous